NextPoint Therapeutics, Inc.
Public SEC Form D filing history for NextPoint Therapeutics, Inc., scored as a sales-ready lead.
| Score | Company | Industry | Raise | Filed |
|---|---|---|---|---|
| 95 | NextPoint Therapeutics, Inc. | Biotechnology | $33,728,772 | 20260730 |
Executives & directors
Self-disclosed on the company's own SEC Form D filing (Item 3).
- Detlev Biniszkiewicz — Director
- Ivan Cheung — Executive Officer, Director
- Axel Hoos — Director
- R. Jacob Vogelstein — Director
- Brian Shuster — Director
- Paulina Hill — Director
- Rakhshita Dhar — Director
- Jeffrey Lacey — Executive Officer
Want to know the moment a company like NextPoint Therapeutics, Inc. files, not weeks later? Free API key, no card required.
See pricing & get a free key